Reviva pharmaceuticals to present at the 2023 bio ceo and investor conference

Cupertino, calif., jan. 31, 2023 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), cardiovascular, metabolic, and inflammatory diseases, today announced that laxminarayan bhat, ph.d., founder, president, and ceo of reviva will present at the bio ceo and investor conference being held february 6–9, 2023 in new york, ny. please see additional details below:
RVPH Ratings Summary
RVPH Quant Ranking